美敦力
MDT
94.75
-0.70
-0.73%
美敦力
US · MDT
#176 按市值排名
上市于 1970
94.75
-0.70
-0.73%
实时 - 追踪5344个代码 - 心跳于410秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了10家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 87.29% +0.02pp
- 机构数量
- 2,532 -10
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund70.97%
Public Company5.71%
Private Company3.40%
Hedge Fund2.77%
Government Pension Fund1.96%
Sovereign Wealth Fund1.39%
Insurance Company0.44%
Family Office/Trust0.30%
Government0.15%
Other12.91%
主要股东 截至 2026-06-30
BlackRock
8.91% · 114.02M 股
Vanguard Capital Management, LLC
7.12% · 91.02M 股
State Street Global Advisors
4.96% · 63.40M 股
Vanguard Portfolio Management, LLC
2.66% · 34.06M 股
Geode Capital Management, LLC
2.36% · 30.19M 股
Other
73.99%
Capital Research
1.69% · 21.65M 股
J.P. Morgan Asset Management, Inc.
1.51% · 19.26M 股
Deutsche Asset & Wealth Management
1.42% · 18.20M 股
Franklin Resources
1.36% · 17.41M 股
MFS Investment Management
1.36% · 17.39M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 28次买入 · 17次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Geoffrey Martha | Chairperson & CEO | 0.02% |
| Randall Hogan | Independent Director | 0.00% |
| Brett Wall | Executive VP & President of Neuroscience Portfolio | 0.00% |
| Craig Arnold | Lead Independent Director | 0.00% |
| Gregory Smith | Executive Vice President of Global Operations & Supply Chain | 0.00% |
| Michael Marinaro | Executive VP & President of Surgical Operating Unit | 0.00% |
| Sean Salmon | Executive VP & President of Cardiovascular Portfolio | 0.00% |
| Matthew Walter | Chief Human Resources Officer | 0.00% |
| Kendall Powell | Independent Director | 0.00% |
| Ivan Fong | General Counsel | 0.00% |
| Scott Donnelly | Independent Director | 0.00% |
| Elizabeth Nabel | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Open Market Disposition | -1,483 | $93.65 |
| 2026-09-14 | Denise Blomquist | Global Controller & Principal Accounting Officer | Other Disposition | -600 | -- |
| 2026-08-19 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Sale to Issuer | -1,084 | $92.30 |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Acquisition | +41,533 | -- |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +103,831 | -- |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +568,152 | $86.68 |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Acquisition | +11,537 | -- |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +28,842 | -- |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +81,945 | $86.68 |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Acquisition | +9,230 | -- |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Derivative Acquisition | +23,074 | -- |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Derivative Acquisition | +65,556 | $86.68 |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Acquisition | +57,107 | -- |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Derivative Acquisition | +27,400 | -- |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Derivative Acquisition | +77,848 | $86.68 |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Acquisition | +6,346 | -- |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Derivative Acquisition | +15,863 | -- |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Derivative Acquisition | +45,070 | $86.68 |
| 2026-08-02 | Kweli Thompson | Operating Unit President of Cardiac Rhythm Management | Other Acquisition | +6,923 | -- |
| 2026-08-02 | Kweli Thompson | Operating Unit President of Cardiac Rhythm Management | Other Derivative Acquisition | +17,306 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:24 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
美敦力 讨论区 0 条评论